Compare FNUC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FNUC | JSPR |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | Canada | United States |
| Employees | N/A | 64 |
| Industry | Other Metals and Minerals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.1M | 34.7M |
| IPO Year | 2021 | N/A |
| Metric | FNUC | JSPR |
|---|---|---|
| Price | $2.07 | $1.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $18.13 |
| AVG Volume (30 Days) | N/A | ★ 257.4K |
| Earning Date | 03-26-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $1.11 |
| 52 Week High | N/A | $7.19 |
| Indicator | FNUC | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 37.23 |
| Support Level | N/A | $1.11 |
| Resistance Level | N/A | $1.44 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 7.14 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.